David Lapointe

$spy very good time to buy puts here on the gap up.

$bmea looking hot again. Ranging between $1.20 and $1.55 in an ascending triangle pattern. Needs to break the $1.55 level.

@apispecunia Yeah no joke lol. $1.35 or higher and we have a nice monthly engulfing candle.

@DavidMLapointe $1.35 huh... 😜 $vvos let's go!!!

$vvos close April over $1.35 and we will have a great Q2.

$vvos well guys looks like we got a pop AH. I bought in before close with half my intended position. The technical target of this move was around $1.70 which it already hit. Let's see how it behaves Monday. We need follow through volume otherwise right back to $1.30.

@Vanderknite Nothing wrong with the stock. Just learn to trade it!

$vvos something could be brewing here...I'm keeping a close watch and will jump back in big and fast if I see certain conditions develop.

$allr great weekly close. I'm expecting continuation upward in the next couple of weeks.

@Nfc_life I'm still optimistic on this stock. This will eventually be a big winner.

@DavidMLapointe 5 months ago told you this going below $1 you were optimistic now we are close to hit that level below $1 surely 🖐🏻.

$vvos target of $1.10 hit in March. Good bounce zone but no clear reversal pattern in place which means this could still go lower on market weakness. $1 is the physiological level.

$bivi I sold my shares in the last minute of trading and it dropped another 10% after my order was fulfilled!

$bivi horrible close today! I'm out at a small loss. Be back later.

$bivi added yesterday. Holding the line surprisingly strong. I'm still liking the setup so I continue to add. I'm keeping an eye on today's close.

$bmea update. I was stopped out of my position for a small loss as my swing setup completely broke down. I won't be touching this again for now.

$allr consolidating nicely in the $1.20 to $1.40 range before the next leg up IMO.

$bivi currently breaking out of this structure with increasing volume. Some announcement around the corner?

$bivi added more this morning in the $1.40s.

$allr the funding they just received is a VERY important clue. They stated that they have a runway until mid 2028. Working backwards, the likely timeline for an accelerated approval is Q1/Q2 2028 or best case late 2027. That tells me they are likely thinking of requesting accelerated approval. This means that they think their interim Phase 2 data is strong. I'm guessing we could get a phase 2 clinical update in the coming weeks with a possible strategy update on whether they intend to pursue accelerated approval. Something is brewing in the charts and I'm here for it.

$allr opened a starter position in pre-market. Momentum building. Will add on dips.

@SilkyJohnstain Yeah not sure what happened here. Momentum was curling then pooufff off a cliff. They supposedly have $173M in cash and barely over $1M in debt. Anyway, I'm staying away.

@DavidMLapointe Bought in at .17 & now down $1200

$ejh never got the confirmation therefore never bought. I'll be removing this off the watch list.